Monti LD - Search Results

1

Alterations in nitric oxide/cyclic-GMP pathway in nondiabetic siblings of patients with type 2 diabetes.

Piatti PM, Monti LD, Zavaroni I, Valsecchi G, Van Phan C, Costa S, Conti M, Sandoli EP, Solerte B, Pozza G, Pontiroli AE, Reaven G. Piatti PM, et al. Among authors: monti ld. J Clin Endocrinol Metab. 2000 Jul;85(7):2416-20. doi: 10.1210/jcem.85.7.6667. J Clin Endocrinol Metab. 2000. PMID: 10902787 Clinical Trial.

2

Determination of plasma [6,6-2H2]glucose enrichment by a simple and accurate gas chromatographic-mass spectrometric method.

Magni F, Monti L, Brambilla P, Poma R, Pozza G, Galli Kienle M. Magni F, et al. J Chromatogr. 1992 Jan 3;573(1):127-31. doi: 10.1016/0378-4347(92)80484-8. J Chromatogr. 1992. PMID: 1564090

3

The effect of intraperitoneal insulin delivery on carbohydrate metabolism in type 1 (insulin-dependent) diabetic patients.

Monti LD, Piatti PM, Home PD, Tomson C, Alberti KG. Monti LD, et al. Diabetes Res Clin Pract. 1992 Mar;15(3):237-44. doi: 10.1016/0168-8227(92)90030-u. Diabetes Res Clin Pract. 1992. PMID: 1576923

4

Intravenous infusion of diarginylinsulin, an insulin analogue: effects on glucose turnover and lipid levels in insulin-treated type II diabetic patients.

Monti LD, Poma R, Caumo A, Stefani I, Picardi A, Sandoli EP, Zoltobrocki M, Micossi P, Pozza G. Monti LD, et al. Metabolism. 1992 May;41(5):540-4. doi: 10.1016/0026-0495(92)90215-v. Metabolism. 1992. PMID: 1588835

5

Growth hormone (GH) autofeedback on GH response to GH-releasing hormone. Role of free fatty acids and somatostatin.

Pontiroli AE, Lanzi R, Monti LD, Sandoli E, Pozza G. Pontiroli AE, et al. Among authors: monti ld. J Clin Endocrinol Metab. 1991 Feb;72(2):492-5. doi: 10.1210/jcem-72-2-492. J Clin Endocrinol Metab. 1991. PMID: 1671389 Clinical Trial.

6

Forearm insulin- and non-insulin-mediated glucose uptake and muscle metabolism in man: role of free fatty acids and blood glucose levels.

Piatti PM, Monti LD, Pacchioni M, Pontiroli AE, Pozza G. Piatti PM, et al. Among authors: monti ld. Metabolism. 1991 Sep;40(9):926-33. doi: 10.1016/0026-0495(91)90068-8. Metabolism. 1991. PMID: 1895958 Clinical Trial.

7

The growth hormone clamp technique: inhibition of growth hormone release by growth hormone occurs independently of free fatty acids.

Lanzi R, Pontiroli AE, Monti LD, Monzani M, Pozza G. Lanzi R, et al. Among authors: monti ld. Metabolism. 1990 Aug;39(8):819-21. doi: 10.1016/0026-0495(90)90125-v. Metabolism. 1990. PMID: 2198432

8

Effect of acipimox, a lipid lowering drug, on growth hormone (GH) response to GH-releasing hormone in normal subjects.

Pontiroli AE, Lanzi R, Monti LD, Pozza G. Pontiroli AE, et al. Among authors: monti ld. J Endocrinol Invest. 1990 Jun;13(6):539-42. doi: 10.1007/BF03348621. J Endocrinol Invest. 1990. PMID: 2258583 Clinical Trial.

9

Secondary failure to oral hypoglycaemic agents in non-obese patients with non-insulin-dependent diabetes is related to reduced insulin release.

Pontiroli AE, Calderara A, Maffi P, Bonisolli L, Carenini A, Piatti PM, Monti LD, Gallus G, Pozza G, Illeni MT. Pontiroli AE, et al. Among authors: monti ld. Diabete Metab. 1989 Mar-Apr;15(2):79-84. Diabete Metab. 1989. PMID: 2661281

10

Effects of arginine and arginine plus somatostatin infusion on insulin release in diabetic patients submitted to pancreas allotransplantation.

Secchi A, Pontiroli AE, Bosi E, Piatti PM, Touraine JL, Monti LD, Gelet A, Traeger J, Dubernard JM, Pozza G. Secchi A, et al. Among authors: monti ld. Diabete Metab. 1987 Jul-Aug;13(4):422-5. Diabete Metab. 1987. PMID: 2890540

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters